Anıl Aktaş-Samur - Concepedia

Author

Anıl Aktaş-Samur

Dana-Farber Cancer Institute

Also Known As

Anil Aktas-Samur, Anıl Aktaş-Samur

Publications

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Bristol-Myers Squibb (United States)VA Boston Healthcare System Harvard University

About

Anıl Aktaş-Samur is an author at Dana-Farber Cancer Institute specializing in cell transplantation, blood transplantation, and marrow transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	12
2	Blood Transplantation	1	1	12
3	Marrow Transplantation	1	1	12
4	Transplantation Surgery	1	1	12
5	Hematology	1	1	12

Anıl Aktaş-Samur

Publications

Citations

H-Index

Page 1

	Year	Citations
High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma Mehmet Samur, Marco Roncador, Anıl Aktaş-Samur, Blood	2020	14
Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş-Samur, Blood	2020	14
Evaluating the Patients with Thalassemia Major for Long-Term Endocrinological Complications After Bone Marrow Transplantation Bilge Aldemir‐Kocabaş, Gülsün Tezcan-Karasu, İffet Bircan, Pediatric Hematology and Oncology Transplantation SurgeryLong-term Endocrinological ComplicationsThalassemia MajorTransplantationMarrow Transplantation	2014	12
Differences in Single Cells between BCMA-Targeting CAR T-Cell Therapy Responders and Non-Responders Reveals Initial Resistance and Acquired Resistance Are Driven By Different Factors Mehmet Samur, Nathan Martin, Ethan Thompson, Blood	2022	10

Page 1